PPPA (drug)
   HOME

TheInfoList



OR:

PPPA, or 3-phenoxy-3-phenylpropan-1-amine, is a
drug A drug is any chemical substance that causes a change in an organism's physiology or psychology when consumed. Drugs are typically distinguished from food and substances that provide nutritional support. Consumption of drugs can be via insuffla ...
which is described as an
antidepressant Antidepressants are a class of medication used to treat major depressive disorder, anxiety disorders, chronic pain conditions, and to help manage addictions. Common side-effects of antidepressants include dry mouth, weight gain, dizziness, hea ...
. It was derived by Eli Lilly from the antihistamine diphenhydramine, a diphenylmethane derivative with additional properties as a selective serotonin reuptake inhibitor (SSRI), and has been the basis for the subsequent discovery of a number of other antidepressant drugs.


List of PPPA derivatives

*
Atomoxetine Atomoxetine, sold under the brand name Strattera, among others, is a medication used to treat attention deficit hyperactivity disorder (ADHD). It may be used alone or along with psychostimulants. It is also used as a cognitive enhancer to impro ...
((3''R'')-''N''-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine) —
NRI NRI or Nri may refer to : * Kingdom of Nri, an Igbo kingdom that flourished between the 10th century and early 20th century * National Radio Institute, a now defunct post-secondary vocational correspondence school * National Resources Inventory * N ...
*
Fluoxetine Fluoxetine, sold under the brand names Prozac and Sarafem, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorde ...
(''N''-methyl-3-(4-(trifluoromethyl)phenoxy)-3-phenylpropan-1-amine) — SSRI * ''N''-Methyl-PPPA (''N''-methyl-3-phenoxy-3-phenylpropan-1-amine) — SNRI *
Nisoxetine Nisoxetine, originally synthesized in the Lilly research laboratories during the early 1970s, is a potent and selective inhibitor for the reuptake of norepinephrine (noradrenaline) into synapses. It currently has no clinical applications in hum ...
(''N''-methyl-3-(2-methoxyphenoxy)-3-phenylpropan-1-amine) — NRI *
Norfluoxetine Seproxetine, also known as (''S'')-norfluoxetine, is a selective serotonin reuptake inhibitor (SSRI). It is the ''S'' enantiomer of norfluoxetine, the main active metabolite of the widely used antidepressant fluoxetine; but little is known abo ...
(3-(4-(trifluoromethyl)phenoxy)-3-phenylpropan-1-amine) — SSRI *
Seproxetine Seproxetine, also known as (''S'')-norfluoxetine, is a selective serotonin reuptake inhibitor (SSRI). It is the ''S'' enantiomer of norfluoxetine, the main active metabolite of the widely used antidepressant fluoxetine; but little is known ...
((''S'')-3-(4-(trifluoromethyl)phenoxy)-3-phenylpropan-1-amine) — SSRI Structurally related drugs include
dapoxetine Dapoxetine, marketed as Priligy, among others, is a medication used for the treatment of premature ejaculation (PE) in men 18–64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin's action at the postsynap ...
, duloxetine,
edivoxetine Edivoxetine (INN; code name LY-2216684) is a drug which acts as a selective norepinephrine reuptake inhibitor and was under development by Eli Lilly for attention-deficit disorder (ADD) and as an antidepressant treatment. It was in phase III ...
,
femoxetine Femoxetine (INN; tentative brand name Malexil; developmental code name FG-4963) is a drug related to paroxetine that was being developed as an antidepressant by Danish pharmaceutical company Ferrosan in 1975 before acquisition of the company by ...
, paroxetine, reboxetine, and viloxazine, all of which act, similarly, as
monoamine reuptake inhibitor A monoamine reuptake inhibitor (MRI) is a drug that acts as a reuptake inhibitor of one or more of the three major monoamine neurotransmitters serotonin, norepinephrine, and dopamine by blocking the action of one or more of the respective monoamine ...
s, and most of which are, again similarly, antidepressants.
Zimelidine Zimelidine (INN, BAN) (brand names Zimeldine, Normud, Zelmid) was one of the first selective serotonin reuptake inhibitor (SSRI) antidepressants to be marketed. It is a pyridylallylamine, and is structurally different from other antidepressants ...
is an antidepressant and SSRI which was derived from the antihistamine pheniramine, which, similarly to its analogues brompheniramine and chlorpheniramine, possesses SNRI properties. Fluvoxamine, another antidepressant and SSRI, was developed from the antihistamine
tripelennamine Tripelennamine, sold under the brand name Pyribenzamine by Novartis, is a drug that is used as an antipruritic and first-generation antihistamine. It can be used in the treatment of asthma, hay fever, rhinitis, and urticaria, but is now less co ...
, which possesses SNDRI actions.


See also

* Development and discovery of SSRI drugs * Aryloxypropanamine scaffold *
Lometraline Lometraline (INN; developmental code name CP-14,368) is a drug and an aminotetralin derivative. A structural modification of tricyclic neuroleptics, lometraline was originally patented by Pfizer as an antipsychotic, tranquilizer, and antiparkins ...


References


Further reading

* Amines Experimental antidepressants Drugs developed by Eli Lilly and Company Serotonin–norepinephrine reuptake inhibitors {{nervous-system-drug-stub